Hengkang Medical Group Co., Ltd.

Shenzhen Stock Exchange 002219.SZ

Hengkang Medical Group Co., Ltd. Market Capitalization on January 27, 2025: USD 1.16 B

Hengkang Medical Group Co., Ltd. Market Capitalization is USD 1.16 B on January 27, 2025, a -4.98% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Hengkang Medical Group Co., Ltd. 52-week high Market Capitalization is USD 1.49 B on November 12, 2024, which is 28.93% above the current Market Capitalization.
Hengkang Medical Group Co., Ltd. 52-week low Market Capitalization is USD 789.86 M on July 29, 2024, which is -31.81% below the current Market Capitalization.
Hengkang Medical Group Co., Ltd. average Market Capitalization for the last 52 weeks is USD 1.11 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shenzhen Stock Exchange: 002219.SZ

Hengkang Medical Group Co., Ltd.

CEO	Mr. Liu Jun
IPO Date	March 6, 2008
Location	China
Headquarters	Jinjiang Industrial Development Zone
Employees	7,803
Sector	Health Care
Industries Pharmaceuticals Hospitals & Clinics Medical Instruments

Description

Hengkang Medical Group Co.,Ltd provides medical services, pharmaceuticals, health care, and daily chemical products in China and internationally. It operates approximately 11 hospitals. The company also manufactures pharmaceutical products in the areas of analgesia, cold, cough, gynecology, cardiovascular, digestive, and urinary systems. In addition, it offers Chinese herbal medicines, infusion, and hemostasis products, as well as daily chemical products. The company was formerly known as Gansu Duyiwei Biological Pharmaceutical Co., Ltd. and changed its name to Hengkang Medical Group Co.,Ltd in January 2014. Hengkang Medical Group Co.,Ltd. was founded in 2001 and is based in Chengdu, China.

Key trends

Past 5 years